| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 139, Issue 12 4116-4121, Copyright © 1987 by American Association of Immunologists
ARTICLES |
JP Brakenhoff, ER de Groot, RF Evers, H Pannekoek and LA Aarden
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.
Human monocytes produce a factor that supports the growth of B lymphocyte hybridoma cells, termed hybridoma growth factor (HGF). By using expression cloning in Escherichia coli of complementary DNA derived from human monocyte-poly(A+) RNA, we selected seven clones producing HGF activity as measured in a bioassay, based on the induction of proliferation of the HGF-dependent B cell hybridoma B9. Sequence analysis of the cDNA revealed that HGF is identical with interferon-beta 2, 26,000 protein, and B cell stimulatory factor-2. One of the active clones contained a cDNA that encoded a recombinant product lacking the 28-amino acid long signal peptide and the first 15 amino acids of the mature protein. Antibodies against the recombinant HGF inhibited the biologic activity of recombinant HGF as well as of monocyte-derived HGF.
This article has been cited by other articles:
|
|
 |
|
  B. K. Pedersen and M. A. Febbraio Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6 Physiol Rev, October 1, 2008; 88(4): 1379 - 1406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Lansdorp Telomeres, stem cells, and hematology Blood, February 15, 2008; 111(4): 1759 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.J. de Winter, G.S. Heyde, K.T. Koch, J. Fischer, J.P. van Straalen, M. Bax, C.E. Schotborgh, K.J. Mulder, G.T. Sanders, J.J. Piek, et al. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty Eur. Heart J., June 2, 2002; 23(12): 960 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Gjertsson, O. H. Hultgren, M. Stenson, R. Holmdahl, and A. Tarkowski Are B Lymphocytes of Importance in Severe Staphylococcus aureus Infections? Infect. Immun., May 1, 2000; 68(5): 2431 - 2434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Citarella, A. Felici, M. Brouwer, J. Wagstaff, A. Fantoni, and C. E. Hack Interleukin-6 Downregulates Factor XII Production by Human Hepatoma Cell Line (HepG2) Blood, August 15, 1997; 90(4): 1501 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Meijer, V. Huysen, R.T.J. Smeenk, and A.J.G. Swaak Profiles of Cytokines (TNF{alpha} and IL-6) and Acute Phase Proteins (CRP and {alpha}1AG) related to the Disease Course in Patients with Systemic Lupus Erythematosus Lupus, December 1, 1993; 2(6): 359 - 365. [Abstract] [PDF]
|
|
|
|
 |
|
 S Davis, T. Aldrich, N. Ip, N Stahl, S Scherer, T Farruggella, P. DiStefano, R Curtis, N Panayotatos, H Gascan, et al. Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses Science, March 19, 1993; 259(5102): 1736 - 1739. [Abstract] [PDF]
|
|
|
|
|
|
A.J.G. Swaak, C. Sintnicolaas, C. Meijer, and R.T. Smeenk Observations on the Interleukin-6 and Acute Phase Protein Profiles in the Disease Course of Patients with Lupus Erythematosus Lupus, May 1, 1992; 1(3): 151 - 155. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
